World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 October 2015
Main ID:  NCT02565550
Date of registration: 30/09/2015
Prospective Registration: No
Primary sponsor: Shandong University
Public title: Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
Scientific title: Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
Date of first enrolment: July 2015
Target sample size: 90
Recruitment status: Recruiting
URL:  https://clinicaltrials.gov/show/NCT02565550
Study type:  Interventional
Study design:  Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment  
Phase:  Phase 4
Countries of recruitment
China
Contacts
Name:     Yanqing Li, MD.PHD
Address: 
Telephone: 86-531-8216923
Email: liyanqing@sdu.edu.cn
Affiliation: 
Name:     Yanqing Li, MD.PhD
Address: 
Telephone:
Email:
Affiliation:  Qilu Hospital
Name:     Yanqing Li, MD.PhD
Address: 
Telephone: 86-531-82169236
Email: liyanqing@sdu.edu.cn
Affiliation: 
Key inclusion & exclusion criteria

Inclusion Criteria:

- the presence of Rome III criteria for IBS ;

- Patients scheduled for colonoscopy examination or having negative screening
examinations

- Aged between 18 and 65 years old

Exclusion Criteria:

- Antibiotic, probiotic or laxative usage within 4 weeks.

- organic gastrointestinal diseases

- Severe systematic disease: diabetes mellitus, hepatic, renal or cardiac dysfunction,
thyroid disease or tumor etc.

- pregnancy or lactation.

- previous major or complicated abdominal surgery.

- severe endometriosis and dementia



Age minimum: 18 Years
Age maximum: 65 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Irritable Bowel Syndrome
Intervention(s)
Dietary Supplement: low FODMAPs
Primary Outcome(s)
changes of symptom scores [Time Frame: 5 months]
Secondary Outcome(s)
microbial composition in different response to low FODMAPs [Time Frame: 5 months]
quality of life in IBS patients [Time Frame: 5 months]
proportion of responders [Time Frame: 3 months]
Secondary ID(s)
2015SDU-QILU-G10
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history